Market Tracker

05/26 5:16pm ET

Immunomedics Inc (NASDAQ:IMMU)

7.72
Delayed Data
As of May 26
 +0.25 / +3.35%
Today’s Change
1.95
Today|||52-Week Range
7.97
+110.35%
Year-to-Date
Biotech Movers: Immunomedics, Aerie, Exelixis
May 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close7.47
Today’s open7.68
Day’s range7.31 - 7.97
Volume6,442,221
Average volume (3 months)3,833,734
Market cap$846.1M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-73.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.01-0.04%
--Quidel Corp+0.36+1.68%
ALRPRBAlere Inc-2.48-0.64%
LNTHLantheus Holdings In...+0.05+0.29%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 24, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts